B3GNT4

Across TCGA pan-cancer cohorts, B3GNT4 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated B3GNT4 data layer compared with 27 for mass-spec protein.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher B3GNT4 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated B3GNT4 expression acts as an unfavorable survival marker.

BLCA and UCEC are the cancer types where B3GNT4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Median	III,IV	0.126	0.494	.007	18	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

B3GNT4–BLCA (DFS)

Open the BLCA breakdown →